Pharmacological Management of Neurodegenerative diseases

A tétel rövid nézete
dc.contributor.advisorPórszász , Róbert
dc.contributor.advisordeptÁltalános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet
dc.contributor.authorMorvaridian, Nikta
dc.contributor.departmentDE--Általános Orvostudományi Kar
dc.contributor.opponentMegyeri, Atila
dc.contributor.opponentHalasi , Barbara Dóra
dc.contributor.opponentdeptÁltalános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet
dc.contributor.opponentdeptÁltalános Orvostudományi Kar::Igazságügyi Orvostani Intézet
dc.date.accessioned2024-11-13T12:15:58Z
dc.date.available2024-11-13T12:15:58Z
dc.date.created2024-10-17
dc.description.abstractGlobally, communities are burdened with significant medical and public health costs due to degenerative illnesses of the neurological system. The three main neurodegenerative disorders are amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), Huntington’s disease (HD), and Alzheimer's disease (AD). Since these illnesses are more common and more severe as people age, more instances are anticipated in the near future as life expectancy continues to climb in many nations. With few exceptions, the relative contributions of genetic and environmental variables to causation remain poorly understood. However, molecular epidemiology methods have shown promise in enhancing disease diagnosis, defining disease prognostic factors, pinpointing genes at high risk for familial neurodegenerative diseases, examining shared genetic variants that could indicate susceptibility to the non-familial forms of these illnesses, and measuring exposure to the environment. The epidemiologic characteristics of PD, AD, HD, and ALS are introduced in this literature, along with the pathophysiology of the underlying disease processes and risk factors that may eventually result in better medical therapy and disease prevention. A few suggestions for the pharmaceutical and non-pharmacological treatment of NDs are included in the chapter's conclusion.
dc.description.courseáltalános orvos
dc.description.courselangangol
dc.description.degreeegységes, osztatlan
dc.format.extent32
dc.identifier.urihttps://hdl.handle.net/2437/382041
dc.language.isoen
dc.rights.accessHozzáférhető a 2022 decemberi felsőoktatási törvénymódosítás értelmében.
dc.subjectNeurodegenerative disease
dc.subject.dspaceMedicine::Pharmacology
dc.titlePharmacological Management of Neurodegenerative diseases
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
Pharmacological_management_reordered.pdf
Méret:
823.58 KB
Formátum:
Adobe Portable Document Format
Leírás:
Megjelenítés
Engedélyek köteg
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
license.txt
Méret:
1.94 KB
Formátum:
Item-specific license agreed upon to submission
Leírás:
Letöltés
Gyűjtemények
Theses (Faculty of Medicine)